European Parliament panel rejects tougher alcohol warnings for wine

European wine producers are welcoming a vote in the European Parliament’s public health committee that rejected tougher language on alcohol-related health risks and stopped short of calling for stronger limits on wine promotion, but the issue is not settled and lawmakers still face a final vote in November.

The vote came in the Parliament’s Committee on Public Health, known as SANT, as members reviewed how the European Union’s Beating Cancer Plan is being carried out. Wine industry groups said the committee preserved a distinction between alcohol consumption in general and harmful consumption, and removed language suggesting there is no safe level of drinking.

That outcome was praised by the European Network of Wine Cities, or RECEVIN, which represents wine-producing municipalities across Europe. In a statement after the vote, RECEVIN President Angelo Radica said the result was positive for wine regions because it avoided what he called the “demonization” of wine and kept a line between moderate consumption and abuse.

Radica said wine-producing areas would consider it unfair to condemn all wine consumption without making that distinction. He also said stricter rules on labeling and advertising could have heavily affected a product with major economic importance in several European countries.

The committee’s text, according to RECEVIN, also recognized the labeling rules already in place for wine on ingredients and nutritional information instead of endorsing stronger health warnings. The group also said proposed restrictions on alcohol marketing at sporting events were narrowed to concerns about exposure to minors, rather than broader limits.

The vote is part of a politically sensitive debate in Europe over whether alcohol policy should treat wine differently because of its cultural and economic role in many regions, or whether all alcoholic drinks should face stronger public health warnings because of their link to cancer and other diseases.

Wine producers and regional officials argue that wine cannot be reduced to a public health problem alone. Public health advocates and the World Health Organization have been pressing in the opposite direction, saying consumers should receive clearer warnings about cancer risks and that policy should not suggest any level of alcohol is risk-free.

The dispute has drawn particular attention in Spain, Italy and France, where wine is tied closely to agriculture, exports and local identity. In Spain, the regional government of Castilla-La Mancha, the country’s largest wine-producing region, publicly welcomed the committee’s decision this week.

Speaking in Brussels on October 13, Castilla-La Mancha’s second vice-president, José Manuel Caballero, said the committee had recognized the arguments made by wine-producing territories against treating wine as inherently harmful. He also defended wine as part of the Mediterranean diet and of the culture of producing regions.

Castilla-La Mancha says about half of Spain’s wine production comes from the region. Regional officials say around 80,000 people depend directly on an industry worth about €2 billion there. According to the regional government, wine exports from Castilla-La Mancha reached €440 million in the first seven months of 2026.

Those figures help explain why the debate over labels and advertising has become an economic issue as well as a health issue. Producers fear that mandatory front-of-pack cancer warnings or broad advertising restrictions could hurt sales and weaken the image of wine in domestic and export markets.

RECEVIN said the committee vote also recognized advances made by the wine sector in providing digital information through QR codes and other tools. That point remains contested by health officials, who argue that key health information should be immediately visible on bottles and not require consumers to scan a code.

The World Health Organization’s Europe office has kept pressure on the European Union to adopt stronger alcohol warnings, especially those linked to cancer. WHO Europe has said no level of alcohol consumption is risk-free in relation to cancer and has argued that health information should be displayed prominently on packaging.

WHO has also pointed to low public awareness of alcohol-related cancer risks. Research published by WHO Europe in February 2025 found that only 15% of respondents in 14 European countries knew alcohol consumption could cause breast cancer. The same survey found that 39% were aware of the link between alcohol and colon cancer.

That gap in public knowledge has become a central argument for those pushing tougher labels. Health advocates say many consumers still associate alcohol risks mainly with addiction, drunk driving or liver disease, while knowing much less about the connection between drinking and several forms of cancer.

The committee vote does not create new EU-wide labeling rules on its own, and it does not end the broader policy fight. The report concerns implementation of the cancer plan rather than direct legislation, and any shift in Parliament’s political position still requires approval by the full assembly.

A plenary vote in the European Parliament is provisionally scheduled for November 11. That vote is expected to show whether the committee’s language survives intact or whether lawmakers restore tougher language on health warnings, alcohol marketing or consumer information.

The outcome will be closely watched by wine producers, regional governments, health officials and consumer groups across the bloc. For the wine industry, the committee vote offered a temporary victory and a sign that lawmakers remain cautious about treating wine the same way as other alcohol products in public messaging. For health advocates, the November vote remains a chance to push for stronger recognition of alcohol’s role in cancer risk.

Until then, both sides are likely to intensify lobbying in Brussels. Wine-producing regions are framing the issue around economic survival, cultural heritage and proportional regulation. Public health groups are framing it around evidence, consumer information and disease prevention. The final vote will determine which of those arguments carries more weight in Parliament’s next statement on Europe’s cancer policy.